Clinical Trial Update: Spironolactone Versus Amiloride as an Add on Agent in Resistant Hypertension [NA]

View source ↗

Summary

Clinical trial comparing spironolactone versus amiloride as add-on therapy in resistant hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aldactone (spironolactone)
• Midamor (Amiloride)

Snippet

Sponsor: VA Salt Lake City Health Care System | Conditions: Hypertension | NA | Status: WITHDRAWN